AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

VOLITIONRX LTD Director's Dealing 2021

Feb 2, 2021

34395_dirs_2021-02-02_b45c17de-82d3-457d-9669-4ffc7f75d289.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-02-01

Reporting Person: Hughes Terig (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct